Effects of Immune System-Related Medications on COVID-19 Outcome in a Cohort of Iranian Patients: Preliminary Report of a Data Mining Study
Background. Regulation of the immune system is critical for fighting against viral infections. Both suppression and hyperactivity of the immune system result in failure of treatment. The present study was designed to show the effects of immune system-related medications on mortality and length of st...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2021/9934134 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832556883460751360 |
|---|---|
| author | Ehsan Bitaraf Seyyed Amir Yasin Ahmadi Alireza Gandomi-Mohammadabadi Zahra Noorani Mejareh Bahare Abdollahi Javad Balasi Farzan Moodi Nima Hemmati Ali Kabir |
| author_facet | Ehsan Bitaraf Seyyed Amir Yasin Ahmadi Alireza Gandomi-Mohammadabadi Zahra Noorani Mejareh Bahare Abdollahi Javad Balasi Farzan Moodi Nima Hemmati Ali Kabir |
| author_sort | Ehsan Bitaraf |
| collection | DOAJ |
| description | Background. Regulation of the immune system is critical for fighting against viral infections. Both suppression and hyperactivity of the immune system result in failure of treatment. The present study was designed to show the effects of immune system-related medications on mortality and length of stay (LOS) in a cohort of Iranian patients with coronavirus disease 2019 (COVID-19). Methods. A data mining study was performed on 6417 cases of COVID-19 covered by 17 educational hospitals of Iran University of Medical Sciences, Tehran. Association of a researcher-designed drug list with death and LOS was studied. For death outcome, logistic regression was used reporting odds ratio (OR) with 95% confidence interval (CI). For LOS, right censored Poisson regression was used reporting incidence rate ratio (IRR) with 95% CI. Results. Among the corticosteroids, prednisolone was a risk factor on death (OR=1.41, 95%CI=1.03−1.94). This association was increased after adjustment of age interactions (OR=3.45, 95%CI=1.01−11.81) and was removed after adjustment of ICU admission interactions (OR=2.64, 95%CI=0.70−9.92). Hydroxychloroquine showed a protecting effect on death (OR=0.735, 95%CI=0.627−0.862); however, this association was removed after adjustment of age interactions (OR=0.76, 95%CI=0.41−1.40). Among the antivirals, oseltamivir showed a protecting effect on death (OR=0.628, 95%CI=0.451−0.873); however, this association was removed after adjustment of age interactions (OR=0.45, 95%CI=0.11−1.82). For reduction of LOS, the only significant association was for hydroxychloroquine (IRR=0.85, 95%CI=0.79−0.92). Conclusion. The results of such data mining studies can be used in clinics until completing the evidence. Hydroxychloroquine may reduce mortality in some specific groups; however, its association may be confounded by some latent variables and unknown interactions. Administration of corticosteroids should be based on the conditions of each case. |
| format | Article |
| id | doaj-art-4a516e04e0b34c429536d5f34077c483 |
| institution | Kabale University |
| issn | 2314-8861 2314-7156 |
| language | English |
| publishDate | 2021-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Immunology Research |
| spelling | doaj-art-4a516e04e0b34c429536d5f34077c4832025-02-03T05:44:08ZengWileyJournal of Immunology Research2314-88612314-71562021-01-01202110.1155/2021/99341349934134Effects of Immune System-Related Medications on COVID-19 Outcome in a Cohort of Iranian Patients: Preliminary Report of a Data Mining StudyEhsan Bitaraf0Seyyed Amir Yasin Ahmadi1Alireza Gandomi-Mohammadabadi2Zahra Noorani Mejareh3Bahare Abdollahi4Javad Balasi5Farzan Moodi6Nima Hemmati7Ali Kabir8Center for Statistics and Information Technology, Central Library, Iran University of Medical Sciences, Tehran, IranStudent Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, IranStudent Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, IranStudent Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, IranStudent Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, IranStudent Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, IranStudent Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, IranMinimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, IranMinimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, IranBackground. Regulation of the immune system is critical for fighting against viral infections. Both suppression and hyperactivity of the immune system result in failure of treatment. The present study was designed to show the effects of immune system-related medications on mortality and length of stay (LOS) in a cohort of Iranian patients with coronavirus disease 2019 (COVID-19). Methods. A data mining study was performed on 6417 cases of COVID-19 covered by 17 educational hospitals of Iran University of Medical Sciences, Tehran. Association of a researcher-designed drug list with death and LOS was studied. For death outcome, logistic regression was used reporting odds ratio (OR) with 95% confidence interval (CI). For LOS, right censored Poisson regression was used reporting incidence rate ratio (IRR) with 95% CI. Results. Among the corticosteroids, prednisolone was a risk factor on death (OR=1.41, 95%CI=1.03−1.94). This association was increased after adjustment of age interactions (OR=3.45, 95%CI=1.01−11.81) and was removed after adjustment of ICU admission interactions (OR=2.64, 95%CI=0.70−9.92). Hydroxychloroquine showed a protecting effect on death (OR=0.735, 95%CI=0.627−0.862); however, this association was removed after adjustment of age interactions (OR=0.76, 95%CI=0.41−1.40). Among the antivirals, oseltamivir showed a protecting effect on death (OR=0.628, 95%CI=0.451−0.873); however, this association was removed after adjustment of age interactions (OR=0.45, 95%CI=0.11−1.82). For reduction of LOS, the only significant association was for hydroxychloroquine (IRR=0.85, 95%CI=0.79−0.92). Conclusion. The results of such data mining studies can be used in clinics until completing the evidence. Hydroxychloroquine may reduce mortality in some specific groups; however, its association may be confounded by some latent variables and unknown interactions. Administration of corticosteroids should be based on the conditions of each case.http://dx.doi.org/10.1155/2021/9934134 |
| spellingShingle | Ehsan Bitaraf Seyyed Amir Yasin Ahmadi Alireza Gandomi-Mohammadabadi Zahra Noorani Mejareh Bahare Abdollahi Javad Balasi Farzan Moodi Nima Hemmati Ali Kabir Effects of Immune System-Related Medications on COVID-19 Outcome in a Cohort of Iranian Patients: Preliminary Report of a Data Mining Study Journal of Immunology Research |
| title | Effects of Immune System-Related Medications on COVID-19 Outcome in a Cohort of Iranian Patients: Preliminary Report of a Data Mining Study |
| title_full | Effects of Immune System-Related Medications on COVID-19 Outcome in a Cohort of Iranian Patients: Preliminary Report of a Data Mining Study |
| title_fullStr | Effects of Immune System-Related Medications on COVID-19 Outcome in a Cohort of Iranian Patients: Preliminary Report of a Data Mining Study |
| title_full_unstemmed | Effects of Immune System-Related Medications on COVID-19 Outcome in a Cohort of Iranian Patients: Preliminary Report of a Data Mining Study |
| title_short | Effects of Immune System-Related Medications on COVID-19 Outcome in a Cohort of Iranian Patients: Preliminary Report of a Data Mining Study |
| title_sort | effects of immune system related medications on covid 19 outcome in a cohort of iranian patients preliminary report of a data mining study |
| url | http://dx.doi.org/10.1155/2021/9934134 |
| work_keys_str_mv | AT ehsanbitaraf effectsofimmunesystemrelatedmedicationsoncovid19outcomeinacohortofiranianpatientspreliminaryreportofadataminingstudy AT seyyedamiryasinahmadi effectsofimmunesystemrelatedmedicationsoncovid19outcomeinacohortofiranianpatientspreliminaryreportofadataminingstudy AT alirezagandomimohammadabadi effectsofimmunesystemrelatedmedicationsoncovid19outcomeinacohortofiranianpatientspreliminaryreportofadataminingstudy AT zahranooranimejareh effectsofimmunesystemrelatedmedicationsoncovid19outcomeinacohortofiranianpatientspreliminaryreportofadataminingstudy AT bahareabdollahi effectsofimmunesystemrelatedmedicationsoncovid19outcomeinacohortofiranianpatientspreliminaryreportofadataminingstudy AT javadbalasi effectsofimmunesystemrelatedmedicationsoncovid19outcomeinacohortofiranianpatientspreliminaryreportofadataminingstudy AT farzanmoodi effectsofimmunesystemrelatedmedicationsoncovid19outcomeinacohortofiranianpatientspreliminaryreportofadataminingstudy AT nimahemmati effectsofimmunesystemrelatedmedicationsoncovid19outcomeinacohortofiranianpatientspreliminaryreportofadataminingstudy AT alikabir effectsofimmunesystemrelatedmedicationsoncovid19outcomeinacohortofiranianpatientspreliminaryreportofadataminingstudy |